@article{da29479f9b7e46379a88d6ad302d3ea1,
title = "Fetal grafts for Parkinson's disease: Decades in themaking",
author = "Kordower, {Jeffrey H.} and Olanow, {C. Warren}",
note = "Funding Information: Conflict of interest statement: J.H.K. receives consulting fees from NsGene and Brainstorm, Inc., and has an NIH grant (NS070577) on induced pluripotent stem cells. C.W.O. is a shareholder in Clintrex. Clintrex provides consulting services for AstraZeneca, Accorda/Civitas/Biotie, Britannia, Corium, Cynapsus, Forward Pharma, Intec, Michael J. Fox Foundation, Lundbeck, Lysosomal Therapeutics, Neuroderm, Neurmedix, Orion, Otsuka/ INC, Prana, Pharma2B, Pfizer, Raptor, Remedy, Sanofie/Genzyme, Serina, Sunovian, Synagile, Upsher Smith, Teva, Titan, USWorldMed, Vaccinex, Vertex, Weston Foundation, and Zambon.",
year = "2016",
month = jun,
day = "7",
doi = "10.1073/pnas.1606342113",
language = "English (US)",
volume = "113",
pages = "6332--6334",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "23",
}